Federal Judge Curtails United Healthcare’s Antitrust Case Against Merck and Glenmark Over Zetia Release

A federal judge in Minnesota has narrowed the scope of an antitrust lawsuit filed by a United Healthcare unit against pharmaceutical companies Merck and Glenmark. The suit alleged that both companies conspired to postpone the release of a generic version of the cholesterol-lowering medication Zetia. The judge dismissed state-law claims from jurisdictions outside Minnesota, labeling them as “bare and conclusory pleading.” For further details on this legal development, visit the full article on Law360.